Leukemia Clinical Trials in Austin

Showing 561-580 of 1,100 trials

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

NCT05094804

This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR2805 administered as a monotherapy and in combination with anti-cancer agents in subjects with advanced solid tumors.

CancerTumor, SolidMalignant Neoplasm+7 more

OncoResponse, Inc.172 participantsStarted Sep 2021

Scottsdale, Arizona, United States • Austin, Texas, United States • San Antonio, Texas, United States

COMPLETEDPhase 368 miles

Mite Asthma Pediatric Immunotherapy Trial

NCT03654976

The trial aims to demonstrate efficacy of the House Dust Mite SLIT-tablet versus placebo as add-on treatment in children and adolescents (5-17 years) with House Dust Mite allergic asthma based on clinically relevant asthma worsening.

Allergic Asthma Due to Dermatophagoides FarinaeAllergic Asthma Due to Dermatophagoides PteronyssinusAllergic Rhinitis Due to House Dust Mite

ALK-Abelló A/S533 participantsStarted Feb 2018

Miami, Florida, United States • Columbus, Georgia, United States • Ypsilanti, Michigan, United States +61 more locations

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Mite Asthma Pediatric Immunotherapy Trial

Leukemia Trials in Other Cities

Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

FX Shoulder Solutions Retrospective / Prospective Clinical Study

The KinematX Midcarpal Total Wrist Arthroplasty Registry

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

International Lung Screen Trial (ILST)

Other Conditions in Austin